Navigation Links
Mr. Robert Andrews Joins Asymchem Life Science (Tianjin) Co. Ltd. as Vice President of Quality Assurance
Date:3/25/2011

MORRISVILLE, N.C., March 25, 2011 /PRNewswire/ -- Asymchem Life Science (Tianjin) Co. Ltd, a leading research-based contract manufacturer of advanced intermediates and API's to the pharmaceutical industry, with sites in the U.S. and China, is pleased to announce the recent addition of Mr. Robert Andrews as Vice President of Quality Assurance as of March 1, 2011.

Mr. Andrews brings to the table over 18 years' experience in the pharmaceutical industry (early and late stage), in quality assurance and quality control. Prior to Asymchem, he worked for solid dosage softgel and softlet manufacturer Banner Pharmacaps, Inc. as a part of their Global Technical Support Management at a total of five plants worldwide. Additionally, Mr. Andrews has worked in many medical and pharmaceutical enterprises in positions such as Senior Consultant of Quality Management at TSI Health Sciences, Inc and Division Quality Manager at Pridecraft Enterprises.

In his previous role, while focusing on quality management and supervision, he handled twenty US FDA, NCDA and DEA Inspections. He has offered technical support and quality management to six API plants and seven solid dosage facilities located throughout China, establishing an experienced foundation for his work coming into Asymchem.

As Vice President of Quality Assurance, Mr. Andrews will have overall responsibility for Asymchem's quality assurance program and management, improving upon Asymchem's cGMP QA management system to align and communicate with customers closely on quality issues. In addition, Mr. Andrews will be responsible for organizing and implementing training with regards to GMP and quality management throughout Asymchem.

"I am very pleased to have Mr. Andrews on board to help strengthen and expand Asymchem's established Quality Assurance program," states Dr Hao Hong, CEO of Asymchem. "With his broad experience in the regulatory and pharmaceutical industry, and proven track record of quality management in API manufacturing, I am confident that our QA program will stay on course for continual improvement."

Asymchem is a leading research-based contract manufacturer specializing in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 15 year track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at www.asymchem.com.


'/>"/>
SOURCE Asymchem Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SGS Robert Burek to Speak at Medical Device Standards Seminar March 24
2. Polaris Group Appoints Robert E. Hoffman as Chief Financial Officer
3. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
4. Uroplasty Announces Addition of Robert Kill to its Board of Directors
5. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
6. CNBC, Discovery Channel and National Geographic to Cover Dr. Robert Melamede and Richard Cowan of Cannabis Science Whom are Speaking at The Marijuana Conference in New York City on Oct. 25 & 26
7. CVS Caremark Appoints Jonathan C. Roberts as PBM Chief Operating Officer
8. Dr. Robert Shorr, Leading Scientist in Cancer Metabolism, to Speak at Two Upcoming Pharmaceutical Conferences
9. Media Statement: Robert Moussa, President and CEO, Dilon Diagnostics
10. North American Spine Welcomes Robert R. Bulger, M.D. to Dallas Physician Group
11. Watson Promotes Robert Stewart to Executive Vice President, Global Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
Breaking Medicine News(10 mins):